Democrats’ TGIF moment, pathologists defend their turf, & Biogen’s back at the FDA’s doorstep
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Category: White House
Here’s who Democrats’ drug pricing bill will actually help
WASHINGTON — Millions of patients in the Medicare program could eventually see lower prescription drug costs…
STAT+: The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended consequences
There’s really no ignoring the inexorable math that led the Senate to approve a plan…
STAT+: Health care industry swarms Washington as surprise billing rules get ironed out
Solving surprise medical bills was supposed to be straightforward. It has been anything but. Already,…
In a massive victory for Democrats, Medicare is poised to negotiate drug prices
WASHINGTON — President Biden is on the verge of his own crowning health care achievement…
Democrats dramatically narrow their ambitions for lowering insulin costs
WASHINGTON — Democrats’ high hopes to lower insulin costs for patients with insurance got downsized on…
Democrats will have to limit their drug pricing reforms to Medicare to comply with Senate rules
WASHINGTON — Democrats will likely have to axe two provisions from their drug pricing plan…
A chaotic sprint to lower insulin prices and AIDS activists go after Biden on monkeypox
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Cities are lobbying to host the ARPA-H headquarters. Experts don’t understand why
WASHINGTON — America’s mayors are drooling over President Biden’s new high-stakes research agency, ARPA-H. They…
Biden tests positive for Covid-19 again — in a case of ‘Paxlovid rebound’
President Biden tested positive for the coronavirus again Saturday, the White House said, an example…
The view on drug pricing from Wall Street, a pharma-friendly Dem holds firm, and what’s next for a big telehealth bill
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Senators demand answers about federal prisons’ scant use of Covid therapeutics
WASHINGTON — Fourteen senators are demanding that the federal Bureau of Prisons explain its scant…
.jpg)
STAT+: ‘What can we do?’: Pharma lobbyists face their biggest test in a decade, as Democrats barrel toward a vote on drug pricing
WASHINGTON — The pharmaceutical industry, notorious for its deep pockets and aggressive lobbying tactics, has a…
Biden picks renowned cancer surgeon Monica Bertagnolli as NCI chief
WASHINGTON — The Biden administration has selected Monica Bertagnolli, a renowned surgical oncologist, as the…
President Biden tests positive for Covid-19, but has ‘very mild symptoms’
President Biden tested positive for Covid-19 Thursday — a coronavirus case that reflects both the…
Virtual Event: Democrats’ Last Chance for Drug Pricing Reform?
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Medicare offers financial perks for rural hospitals that convert to its new provider type. Will they bite?
The federal government is hashing out the details on a new type of rural hospital,…
PhRMA and BIO descend on D.C. & unpacking the Senate’s FDA funding drama
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
.jpg)
Biden tells Dems to quickly pass pared-down economic package
WASHINGTON (AP) — President Joe Biden seemed to bow Friday to Sen. Joe Manchin’s demand…
STAT+: In a high-profile misstep, the FDA backtracks on its ban on Juul
WASHINGTON — The FDA suddenly reversed course this week on its efforts to ban Juul…
STAT+: Here’s what Democrats changed in their latest drug pricing bill
WASHINGTON — Senate Democrats have put final tweaks on their drug pricing proposal, as they…
STAT+: In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans
WASHINGTON — The White House is zeroing in on former DARPA officials as candidates to…
The unlikely crusader who’s winning the fight to lower hospital prices
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Despite fanfare, the FDA’s step toward lowering nicotine levels in cigarettes is a very early one
WASHINGTON — When the Food and Drug Administration said Tuesday it would eventually lower the…
STAT+: Congress is closer than ever to formally authorizing ARPA-H. But the details aren’t as final as they seem
WASHINGTON — It seemed like the debate over President Biden’s new high-stakes science agency, ARPA-H,…
STAT+: Supreme Court sides with hospitals on Medicare drug pay dispute
WASHINGTON — The Supreme Court on Wednesday sided with hospitals in a legal dispute over…
STAT+: New Jersey hospitals scrap merger after FTC challenge
Two New Jersey hospital systems have called off their proposed merger less than two weeks…
STAT+: Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb
WASHINGTON — Two prominent Democratic lawmakers are requesting that the Federal Trade Commission investigate whether…
Francis Collins on his new life as White House science adviser
WASHINGTON — Francis Collins’ 2022 hasn’t exactly gone according to plan. The mustachioed, Harley-riding geneticist…
STAT+: The FTC says it’s getting tougher on hospital consolidation. Antitrust experts aren’t buying it
After the Federal Trade Commission’s flashy announcements last week that it was suing to block…
‘Too little too late’: Unpacking Biden’s moves to improve federal prisons’ response to Covid-19
WASHINGTON — The Biden administration is trying to finally unsnarl the federal Bureau of Prisons’…
STAT+: Francis Collins: Concern about independence of new moonshot science agency ARPA-H are ‘overblown’
WASHINGTON — Francis Collins thinks the debate surrounding the Biden administration’s new high-stakes research agency…
How the Covid-19 pandemic prepared the White House to respond to monkeypox
WASHINGTON — The man at the center of the White House’s biodefense strategy is only…
STAT+: Justice Department says sweeping lab test fraud in Texas involved dozens of doctors and front companies
A new Justice Department lawsuit describes a sweeping fraud scheme in which dozens of Texas…
Biden administration won’t lower seniors’ Medicare premiums this year, despite changes to coverage of new Alzheimer’s drug
WASHINGTON — The Biden administration on Friday said it will not lower Medicare premiums for…
A no good, very bad week for the FDA
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
AstraZeneca’s ambitious vaccine dreams are finally, officially dead
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: AbbVie dramatically boosts its spending on lobbying
WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three…
As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
What happens when the government stops buying Covid-19 vaccines?
WASHINGTON — The federal government has distributed Covid-19 vaccines and treatments for free so far,…
STAT+: Flagship Pioneering hires lobbyists, a first among biotech venture firms
WASHINGTON — Flagship Pioneering, the venture capital firm behind Moderna, is getting into the Washington…
STAT+: The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years
WASHINGTON — An oversight board tasked with making the National Institutes of Health more efficient…
White House documents detail a looming squeeze on Covid-19 boosters
WASHINGTON — The White House could run out of Covid-19 vaccines if it moves forward…
Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs
Federal prisons utilized just a fraction of the antiviral drugs they were allocated to keep…
STAT+: Medicare’s Brooks-LaSure expects restrictions on accelerated approval drugs, like those for Aduhelm, to be ‘very rare’
AUSTIN, Texas – Chiquita Brooks-LaSure, the head of Medicare, said on Thursday that the agency…
Covid’s circling the White House. What are the risks to someone like Biden?
For weeks, the coronavirus has been closing in on the Oval Office. In late March,…
STAT+: Manchin won’t support new health policy unless Congress rolls back Trump tax cuts
WASHINGTON — Sen. Joe Manchin, a moderate Democrat who will determine how much domestic policy…
The FDA’s ban on menthol in cigarettes clears a major regulatory hurdle
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….
White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process
WASHINGTON — It was a striking visual for the television cameras. White House Press Secretary…
A new nonprofit wants to rewrite the playbook for how the U.S. government funds science
WASHINGTON — The Good Science Project is hoping to push the NIH and other government…